Publications

Patents portfolio

Granted and pending patents covering compounds, methods and systems developed by the group — covering oncology, antivirals, metabolic disease, anti-aging and HPC drug-discovery methodology.

← All publications See clinical pipeline →

Total patents

Licensed

Clinical stage

Filed

2023

Synergistic combination for the treatment of cancer

Cancer combination therapy

H. Pérez-Sánchez, M. Tomczyk, H. Legierski, K. Matczak, A. Kubicka, M. Łabieniec-Watała

P202330324 (2023)

Patent filed

2022

Compuestos antienvejecimiento

Anti-aging compounds

M.L. Cayuela Fuentes, F. Alcaraz-Pérez, D. Hernández Silva, H. Pérez-Sánchez, V. Mulero Méndez, J. Cantón Sandoval

P202230840 (2022)

Patent filed

2021

Raltegravir for use as inhibitor of Fascin1 in cancer

Fascin1 inhibitor (repurposing)

P. Conesa-Zamora, B. Alburquerque-González, H. Pérez-Sánchez, S. Montoro-García, J. García-Solano, et al. (13 inventors)

P202130062 (2021)

Patent filed

2021

Nuevo tratamiento del cáncer colorrectal

Colorectal cancer treatment

H. Pérez-Sánchez, I. Martínez-Martínez, J. Peña-García, A. Rodenas-Bleda, J. Peñas-Martínez, D. Zaragoza-Huesca

P202130064 (2021)

Patent filed

2021

Tratamiento para la obesidad

Obesity treatment

H. Pérez-Sánchez, J. Peña-García, C. Martínez-Cortés, JJ. Hernández-Morante, T. Castillo, J. Maldonado

P202130278 (2021)

Patent filed

2021

Zeaxantina para la prevención y tratamiento de la infección viral, preferiblemente por coronavirus

Zeaxanthin antiviral (coronavirus)

H. Pérez-Sánchez, I. Martínez-Martínez, D. Zaragoza-Huesca, C. Martínez-Cortés, A.J. Banegas-Luna, et al. (10 inventors)

P202130873 (2021)

Patent filed

2021

Kukoamina A para la prevención y tratamiento de la infección viral, preferiblemente por coronavirus

Kukoamine A antiviral (coronavirus)

H. Pérez-Sánchez, I. Martínez-Martínez, D. Zaragoza-Huesca, C. Martínez-Cortés, A.J. Banegas-Luna, et al. (10 inventors)

P202130872 (2021)

Patent filed

2021

Nuevo tratamiento del cáncer colorrectal (II)

Colorectal cancer treatment (second)

H. Pérez-Sánchez, I. Martínez-Martínez, J. Peña-García, A. Carmona-Bayonas, M. Rodenas-Bleda, et al. (10 inventors)

P202130871 (2021)

Patent filed

2020

Methods of treating coronavirus using antiviral therapies

Antiviral methods (coronavirus)

H. Pérez-Sánchez, J.P. Cerón-Carrasco, J. Peña-García

US62991012 (2020)

Patent licensed

2020

Methods of treating and preventing coronavirus infection and disrupting coronavirus replication

Coronavirus replication disruption

H. Pérez-Sánchez, J.P. Cerón-Carrasco, J. Peña-García, A. Pérez-Garrido, A.J. Banegas-Luna

US63081464 (2020)

Patent licensed

2018

Imipramine for use as inhibitor of fascin1 overexpression

Fascin1 inhibitor → colorectal cancer

P. Conesa-Zamora, H. Pérez-Sánchez, I. Luque-Fernández, S. Montoro-García, B. Alburquerque-González, et al. (14 inventors)

EP18382696.5 (2018)

Patent licensedClinical-stageClinical Murcia 2022

2017

Zika Virus Protease Inhibitors and Methods of Use Thereof

Zika virus protease inhibitors

S. Yuan, J.F. Chan, K. Yuen, H. den-Haan, J. Peña-García, et al. (7 inventors)

PCT/CN2017/088420, US 62491007 (2017)

Patent licensed

2012

A Molecular Scaffold to Modulate Thrombin/Antithrombin Activity by Heparin Binding

Thrombin/antithrombin modulator

H. Pérez-Sánchez, I. Meliciani, W. Wenzel, I. Martínez-Martínez, J. Navarro-Fernández, et al. (7 inventors)

EP2505202 A1 (2012), WO2012130448 A1 (2012)

Patent filed

2011

Method and system for determining the solvent accessible surface area and its derivatives of a molecule

SASA computation method

K. Klenin, H. Pérez-Sánchez, W. Wenzel

EP2363820 A1 (2011), US8589137 B2 (2013)

Patent licensedLicensed 2015

Source: Horacio Pérez-Sánchez CV (January 2025). For licensing enquiries contact hperez@ucam.edu.

Patents portfolio

Sign up to receive periodic updates about last research results, software tools (recently published and in testing -premiere access-), open positions, grant calls, press releases, etc.